Adjuvant therapy in the treatment of non-small-cell lung cancer

Anne M. Traynor, Joan H. Schiller

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.

Original languageEnglish (US)
Pages (from-to)161-167
Number of pages7
JournalClinical lung cancer
Issue number3
StatePublished - Nov 2002


  • Chemotherapy
  • Postoperative period
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research


Dive into the research topics of 'Adjuvant therapy in the treatment of non-small-cell lung cancer'. Together they form a unique fingerprint.

Cite this